Avastin plus chemotherapy for metastatic colorectal cancer increases over time
Results of a recent study demonstrate that the proportion of patients with metastatic colorectal cancer treated with the chemotherapy regimen FOLFOXIRI and Avastin (bevacizumab) increases over time, especially in patients younger than 50 years. . Results of this study were presented at the 2024 ASCO Gastrointestinal Cancer Symposium. FOLFOXIRI is a chemotherapy regimen consisting of […]
Fecal microbiota transplant increases survival in metastatic colorectal cancer treatment
In a recent study published in e-clinical medicineresearchers are evaluating the use of fecal microbiota transplantation to increase the efficacy of anti-programmed cell death protein 1 (PD-1) therapy for patients with microsatellite-stable metastatic colorectal cancer. study: Fecal microbiota transplantation with tislelizumab and fruquintinib in refractory microsatellite-stable metastatic colorectal cancer: an open-label, single-arm, phase II study […]
NAFLD increases risk of colorectal adenomatous polyps
Top line: Non-alcoholic fatty liver Results from a large study show that NAFLD is an independent risk factor for precancerous colorectal adenomatous polyps in men and women. methodology: Researchers retrospectively examined medical records of adults who underwent abdominal ultrasound; colonoscopy The study was conducted at a single hospital in China from January 2018 to December […]